| Financial Year |
March 31 2023 |
| Monetary Funds |
67,828,946.20 |
| Held-for-trading Financial Assets |
63,373,701.08 |
| Notes Receivable |
-- |
| Accounts Receivable |
38,836,923.26 |
| Advances to Suppliers |
59,231,089.73 |
| Other Receivables |
20,153,276.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
383,864,041.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,392,303.73 |
| Total Current Assets |
649,680,282.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,444,954.65 |
| Investment Properties |
11,615,608.16 |
| Fixed Assetes |
242,745,982.97 |
| Under-construction Projects |
1,811,050.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
61,061,615.16 |
| R&D expenses |
-- |
| Goodwill |
7,732,337.51 |
| Long-Term Deferred and Prepaid Expenses |
26,409,360.50 |
| Deferred Income Tax Assets |
11,481,114.56 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
478,552,258.23 |
| Total Assets |
1,128,232,540.31 |
| Short-Term Loans |
187,251,481.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
36,237,732.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,288,330.26 |
| Taxes Payable |
2,786,874.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
30,431,971.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
34,633,351.21 |
| Other Current Liabilities |
4,836,227.57 |
| Sub-Total of Current Liabilities |
356,231,393.74 |
| Long-term Loans |
455,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
481,867.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
81,756,452.77 |
| Total Liabilities |
437,987,846.51 |
| Paid-In Capital(Or Share Stock) |
157,587,486.00 |
| Capital Surplus |
495,347,948.96 |
| Surplus Reserve |
18,176,720.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-11,153,675.92 |
| Minority Stockholder's Interest |
30,286,214.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
659,958,479.25 |
| Owner's Equity（Stockholder's Equity） |
690,244,693.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,128,232,540.31 |
